Suppr超能文献

口服庆大霉素、甲硝唑和考来烯胺在治疗婴儿严重持续性腹泻中的应用。

Use of oral gentamicin, metronidazole, and cholestyramine in the treatment of severe persistent diarrhea in infants.

作者信息

Hill I D, Mann M D, Househam K C, Bowie M D

出版信息

Pediatrics. 1986 Apr;77(4):477-81.

PMID:3960616
Abstract

Oral gentamicin, metronidazole, and cholestyramine were given either as single agents or in various combinations to infants who still required treatment after seven days in the hospital for persistent diarrhea. The effect of these drugs and the interactions between them were assessed by comparing daily stool output during treatment with that in the pretreatment period. The effect of the drugs on apparent nitrogen and fat absorption was also studied. On the first day of treatment the presence of cholestyramine was associated with a significantly greater decrease in stool output. This effect appeared to be largely due to an interaction with gentamicin. Thereafter, only gentamicin produced a significantly greater decrease in stool weight. At no stage was metronidazole of benefit. Gentamicin and cholestyramine also indirectly improved apparent nitrogen and fat absorption by reducing stool output. The combination of oral gentamicin and cholestyramine is recommended as a safe and effective way of treating infants with severe persistent diarrhea following acute gastroenteritis.

摘要

对于那些在医院住院七天后仍因持续性腹泻而需要治疗的婴儿,给予口服庆大霉素、甲硝唑和考来烯胺,这些药物要么单独使用,要么以各种组合形式使用。通过比较治疗期间的每日粪便排出量与治疗前期的粪便排出量,评估这些药物的效果以及它们之间的相互作用。还研究了这些药物对表观氮和脂肪吸收的影响。在治疗的第一天,考来烯胺的存在与粪便排出量的显著更大幅度减少有关。这种效果似乎主要是由于与庆大霉素的相互作用。此后,只有庆大霉素使粪便重量显著更大幅度减少。在任何阶段,甲硝唑都没有益处。庆大霉素和考来烯胺还通过减少粪便排出量间接改善了表观氮和脂肪吸收。推荐口服庆大霉素和考来烯胺的组合作为治疗急性胃肠炎后患有严重持续性腹泻婴儿的一种安全有效的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验